Study examines usability of hybrid closed-loop insulin pump

Data from an 83-person study of Medtronic‘s (NYSE:MDT) MiniMed 670G hybrid closed-loop insulin pump showed that nearly one-fifth of participants stopped using the device after struggling with the technical demands of the system, researchers reported.
Medtronic’s MiniMed 670G device is designed to automatically track and adjust a patient’s blood sugar levels by measuring blood glucose every five minutes and automating the administration of insulin.
Get the full story at our sister site, Drug Delivery Business News.
The post Study examines usability of hybrid closed-loop insulin pump appeared first on MassDevice.

Source: Mass Device - March 25, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Featured Pharmaceuticals Boston Children's Hospital Medtronic Source Type: news